ClinicalTrials.gov
ClinicalTrials.gov Menu

Internet Cognitive Behavior Therapy (CBT) for Obsessive Compulsive Disorder (OCD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01348529
Recruitment Status : Completed
First Posted : May 5, 2011
Last Update Posted : March 21, 2018
Sponsor:
Information provided by:
Karolinska Institutet

Brief Summary:
The main aim of this study is to test whether cognitive behavior therapy could be effective in treating obsessive compulsive disorder. Here, the investigators test the in group effects of a 15 week long treatment delivered via the Internet for residents in Stockholm County.

Condition or disease Intervention/treatment Phase
Obsessive Compulsive Disorder Behavioral: Internet CBT Not Applicable

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 23 participants
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Internet-based Cognitive Behavior Therapy for Obsessive Compulsive Disorder: A Pilot Study
Actual Study Start Date : September 2010
Actual Primary Completion Date : March 2011
Actual Study Completion Date : March 2011

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Arm Intervention/treatment
Experimental: Internet CBT
Internet-delivered cognitive behavioral therapy with therapist support.
Behavioral: Internet CBT
Internet-delivered cognitive behavioral therapy with therapist support.



Primary Outcome Measures :
  1. Change from Baseline of obsessions and compulsions after 15 weeks and 6 months after treatment. [ Time Frame: Psychiatrist visit at baseline, after 15 weeks of treatment and 6 months after treatment. ]
    Yale Brown Obsessive Compulsive Scale (Y‐BOCS)


Secondary Outcome Measures :
  1. Change from Baseline of cost data after 15 weeks and 6 months after treatment. [ Time Frame: Self-ratings at baseline, after 15 weeks of treatment and 6 months after treatment. ]
    "Trimbos and Institute of Medical Technology Assessment Cost Questionnaire for Psychiatry". In this questionnaire, patients register their monthly health care consumption (e.g. GP visits) as well as time spent in informal health enhancing activities (e.g. self-help groups and informal care from friends). In addition, work loss and work cutback both at work and in the domestic realm is measured.

  2. Change from Baseline of depressive symptoms after 15 weeks and 6 months after treatment. [ Time Frame: Sel-ratings at baseline, after 15 weeks of treatment and 6 months after treatment. ]
    The Montgomery Åsberg Depression Rating Scale

  3. Change from Baseline of obsessions and compulsions after 15 weeks and 6 months after treatment. [ Time Frame: Self-ratings at baseline, after 15 weeks of treatment and at 6 months after treatment. ]
    Obsessions and Compulsions Inventory Revised

  4. Change from Baseline of quality of life after 15 weeks and 6 months after treatment [ Time Frame: Self-ratings at baseline, after 15 weeks of treatment and at 6 months after treatment. ]
    EuroQol

  5. Change from Baseline of quality of life after 15 weeks and 6 months after treatment [ Time Frame: Self-ratings at baseline, after 15 weeks of treatment and at 6 months after treatment. ]
    Quality of life inventory



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Diagnosed with Obsessive compulsive disorder according to the DSM criteria
  • Be at least 18 years old
  • YBOCS >7

Exclusion Criteria:

  • other primary diagnosis
  • substance abuse,
  • psychosis,
  • bipolar disorder,
  • suicidal ideation,
  • adjusted pharmacological treatment the last two months
  • current psychological treatment for OCD,
  • been treated with CBT the last two years,
  • serious somatic disease,
  • Y--‐BOCS>31
  • hoarding as primary OCD subtype

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01348529


Locations
Sweden
Internetpsykatrienheten, M46, Psykiatri sydväst
Stockholm, Sweden, SE-141 86
Sponsors and Collaborators
Karolinska Institutet

Additional Information:
Publications of Results:
Responsible Party: Christian Rück, MD, PhD, Study Principal Investigator, Karolinska Institutet, Sweden
ClinicalTrials.gov Identifier: NCT01348529     History of Changes
Other Study ID Numbers: OCDP1
First Posted: May 5, 2011    Key Record Dates
Last Update Posted: March 21, 2018
Last Verified: September 2010

Keywords provided by Karolinska Institutet:
OCD
CBT
Reducing OCD symptoms

Additional relevant MeSH terms:
Disease
Compulsive Personality Disorder
Obsessive-Compulsive Disorder
Pathologic Processes
Personality Disorders
Mental Disorders
Anxiety Disorders